Literature DB >> 9420765

The birth of a new radiopharmaceutical. Clinical development and testing.

B L Holman1, A G Jones.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 9420765     DOI： 10.1016/s1071-3581(05)80011-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  15 in total

Review 1.  Functional brain SPECT: the emergence of a powerful clinical method.

Authors:  B L Holman; M D Devous
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

2.  Intercomparison of myocardial imaging agents: 201Ti, 129Cs, 43K, and 81Rb.

Authors:  H Nishiyama; V J Sodd; R J Adolph; E L Saenger; J T Lewis; M Gabel
Journal:  J Nucl Med       Date:  1976-10       Impact factor: 10.057

3.  Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris.

Authors:  B L Zaret; H W Strauss; N D Martin; H P Wells; M D Flamm
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  The submission of I.N.D. applications for radiopharmaceutical research: when and why.

Authors:  D P Swanson; R P Lieto
Journal:  J Nucl Med       Date:  1984-06       Impact factor: 10.057

5.  FDA letter to radioactive drug research chairpersons.

Authors:  R Temple
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

6.  Radiopharmaceuticals and FDA: a clinician's perspective.

Authors:  B A Siegel
Journal:  Med Instrum       Date:  1981 Nov-Dec

7.  Guidelines for the clinical evaluation of radiopharmaceutical drugs.

Authors:  S M Larson; B A Siegel; R G Robinson
Journal:  J Nucl Med       Date:  1978-12       Impact factor: 10.057

8.  Myocardial imaging with technetium-99m CPI: initial experience in the human.

Authors:  B L Holman; V Sporn; A G Jones; S T Sia; N Perez-Balino; A Davison; J Lister-James; J F Kronauge; A E Mitta; L L Camin
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

9.  Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.

Authors:  G M Pohost; L M Zir; R H Moore; K A McKusick; T E Guiney; G A Beller
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.